No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Individual Investors Who Own 57% Along With Institutions Invested in Oculis Holding AG (NASDAQ:OCS) Saw Increase in Their Holdings Value Last Week
Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities
BofA Securities Maintains Oculis(OCS.US) With Buy Rating
Oculis to Present at the Stifel 2024 Healthcare Conference
HC Wainwright & Co. Reiterates Buy on Oculis Holding, Maintains $30 Price Target
Oculis Holding's Promising Clinical Advancements and Market Potential Drive Buy Rating
No Data